Simply Better Brands Corp. (SBBC.V)
CAD 1.03
(1.98%)
CAD 1.03
(1.98%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 552.39 Thousand USD | -45.65% |
| 2022 | 1.01 Million USD | -76.46% |
| 2021 | 4.31 Million USD | -66.04% |
| 2020 | 12.71 Million USD | 14618.31% |
| 2019 | 86.38 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.08 Million USD | -1.14% |
| 2024 Q1 | 1.1 Million USD | 99.17% |
| 2023 Q2 | 1.04 Million USD | -3.37% |
| 2023 FY | 552.39 Thousand USD | -45.65% |
| 2023 Q4 | 552.39 Thousand USD | 6.15% |
| 2023 Q1 | 1.08 Million USD | 6.88% |
| 2023 Q3 | 520.41 Thousand USD | -50.41% |
| 2022 Q4 | 1.01 Million USD | 153.91% |
| 2022 FY | 1.01 Million USD | -76.46% |
| 2022 Q3 | 400.25 Thousand USD | 0.0% |
| 2022 Q2 | - USD | -100.0% |
| 2022 Q1 | 3.64 Million USD | -15.54% |
| 2021 Q4 | 4.31 Million USD | -65.91% |
| 2021 FY | 4.31 Million USD | -66.04% |
| 2021 Q2 | 12.38 Million USD | 2.55% |
| 2021 Q1 | 12.08 Million USD | -4.98% |
| 2021 Q3 | 12.66 Million USD | 2.23% |
| 2020 Q3 | 195.88 Thousand USD | 0.0% |
| 2020 Q4 | 12.71 Million USD | 6390.51% |
| 2020 FY | 12.71 Million USD | 14618.31% |
| 2019 Q4 | 86.38 Thousand USD | 0.0% |
| 2019 FY | 86.38 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 583.58 Thousand CAD | 5.345% |
| CanadaBis Capital Inc. | 5.91 Million CAD | 90.663% |
| Decibel Cannabis Company Inc. | 32.34 Million CAD | 98.292% |
| Delivra Health Brands Inc. | 1.78 Million CAD | 69.054% |
| Entourage Health Corp. | 5.79 Million CAD | 90.465% |
| Lifeist Wellness Inc. | 868.65 Thousand CAD | 36.409% |
| Cannara Biotech Inc. | 39.73 Million CAD | 98.61% |
| Medicure Inc. | 229 Thousand CAD | -141.219% |
| PharmaCielo Ltd. | 2.55 Million CAD | 78.367% |
| Rubicon Organics Inc. | - CAD | -Infinity% |
| BioSyent Inc. | 1.03 Million CAD | 46.769% |
| Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -1280.978% |